<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02791295</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A00481-50</org_study_id>
    <nct_id>NCT02791295</nct_id>
  </id_info>
  <brief_title>Lifestyle Intervention in Type 2 Diabetes</brief_title>
  <acronym>WeightPump</acronym>
  <official_title>Diet and Physical Activity Lifestyle Intervention to Prevent Body Weight Gain in Patients With Type 2 Diabetes Starting Insulin Pump Treatment: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icadom</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AGIR à Dom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Icadom</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether a personalized lifestyle intervention&#xD;
      focused on diet and physical activity reinforcement is effective in avoiding weight gain in&#xD;
      the first months following initiation of subcutaneous insulin pump therapy in type-2 diabetic&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with type 2 diabetes using insulin pump therapy are gaining weight within the first&#xD;
      months of treatment. This weight gain could counterbalance the metabolic benefice of insulin&#xD;
      pump treatment in improving glycemic control and could lead to treatment dropout. Lifestyle&#xD;
      intervention aiming at improving physical activity and diet in type 2 diabetes is known to&#xD;
      brought body weight reduction and cardiometabolic improvement.&#xD;
&#xD;
      The investigator hypothesized that an intensive, home-based, 6-months diet and physical&#xD;
      activity program could prevent the body weight gain associated with insulin pump treatment&#xD;
      initiation. The investigator will randomize patients with type 2 diabetes into a &quot;lifestyle&#xD;
      intervention&quot; arm or a &quot;usual care&quot; control arm at the time of insulin pump treatment&#xD;
      initiation. The primary objective will evaluate body weight change at 6 months after insulin&#xD;
      pump treatment initiation. The secondary objectives will evaluate change in glycemic control&#xD;
      (HbA1c) and body composition at 6 months. In addition, the retention effect will be assessed&#xD;
      on body weight change one year after insulin pump treatment initiation, 6 months after the&#xD;
      end of the lifestyle intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 4, 2016</start_date>
  <completion_date type="Actual">March 17, 2021</completion_date>
  <primary_completion_date type="Actual">January 19, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight change</measure>
    <time_frame>6 months</time_frame>
    <description>The difference in body weight changes between the two groups over a six-month period following initiation of insulin pump treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>6 months</time_frame>
    <description>The difference in HbA1c changes between the two groups after 6-months of insulin pump treatment initiation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>6 months</time_frame>
    <description>The difference between the two groups in distribution of fat mass and lean mass between the first visit and 6 months after initiation of insulin pump treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Treatment Satisfaction</measure>
    <time_frame>6 months</time_frame>
    <description>The difference between the two groups of scores of the Diabetes Treatment Satisfaction Questionnaire between the first visit and 6 months after initiation of insulin pump treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intermediate weight change</measure>
    <time_frame>3 months</time_frame>
    <description>The difference in weight changes between the two groups after 3-months of insulin pump treatment initiation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retention of weight change</measure>
    <time_frame>1 year</time_frame>
    <description>The difference in weight changes between the two groups at 12-months of insulin pump treatment initiation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Type 2 Diabetes Treated With Insulin</condition>
  <arm_group>
    <arm_group_label>Diet and physical activity program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diet and physical activity program with individual coaching</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet and physical activity program</intervention_name>
    <description>A personalized intervention focused on improving diet and increasing physical activity will be implemented at-home with a monthly support by a registered dietician and physical activity educator during 6 months</description>
    <arm_group_label>Diet and physical activity program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult Type 2 diabetic patients with indication of initiation of insulin pump therapy.&#xD;
&#xD;
          -  Patients addressed for the insulin pump follow-up to the home care provider supporting&#xD;
             the study.&#xD;
&#xD;
          -  Public health care security affiliation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Breastfeeding or pregnant woman.&#xD;
&#xD;
          -  Not willing to participate as assessed by the investigator.&#xD;
&#xD;
          -  Patient engaged in another clinical trial with exclusion criteria for other protocol.&#xD;
&#xD;
          -  Patients unable to ride a training bike.&#xD;
&#xD;
          -  Unavailable in the next 6 months.&#xD;
&#xD;
          -  Patient without a medical certificate done in the last 12 months by a cardiologist&#xD;
             attesting the ability to participate in a physical activity reinforcement program.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Laure Borel, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Annecy-Genevois Hospital</name>
      <address>
        <city>Annecy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pierre Oudot Hospital</name>
      <address>
        <city>Bourgoin-Jallieu</city>
        <zip>38302</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Métropole Savoie Hospital</name>
      <address>
        <city>Chambéry</city>
        <zip>73000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alpes Léman Hospital</name>
      <address>
        <city>Contamine-sur-Arve</city>
        <zip>74130</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marseille European Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 1, 2016</study_first_submitted>
  <study_first_submitted_qc>June 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2016</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>lifestyle intervention</keyword>
  <keyword>insulin pump treatment</keyword>
  <keyword>body weight</keyword>
  <keyword>body composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

